Here, we took advantage of the whole-genome CRISPR knock-out screening to analyze whether, several genes involved in ferroptosis are differentially required in tumor cells having mutations in the RAS genes (KRAS, NRAS and HRAS) and those harboring KRAS-WT. The gene discussed is NRAS; the disease is neoplasm.